Skip to content

Problem-Solving Skills Training for Parents of Children Undergoing Hematopoietic Stem Cell Transplantation: A Feasibility Study

Problem-Solving Skills Training for Parents of Children Undergoing Hematopoietic Stem Cell Transplantation: A Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07219524
Enrollment
38
Registered
2025-10-22
Start date
2020-11-11
Completion date
2023-05-23
Last updated
2025-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stem Cell Transplantation

Keywords

Problem-Solving Skills Training, Parent or caregiver support, behavioral intervention

Brief summary

The goal of this clinical trial is to test the feasibility and acceptability of the Bright IDEAS problem-solving skills training (PSST) intervention for parents of children undergoing hematopoietic stem cell transplantation (HSCT). The main question aims to answer: * Determine the feasibility and acceptability of a multimodal PSST intervention for English and Spanish-speaking parents of children and adolescents undergoing autologous and allogeneic HSCT using a randomized controlled trial design and mixed methods approach to evaluation * To evaluate the effectiveness of a PSST intervention on PSS acquisition and psychological distress compared to a control group of parents receiving non-directive psychosocial care (n=25). * To explore the effect of the parent PSST on child quality of life (QoL) and self-reported symptoms, mediated by parent psychological distress If there is a comparison group: Researchers will compare PSST intervention usual or standard psychosocial care. Participants will complete 6-8 sessions of intervention. All participants will complete surveys.

Interventions

BEHAVIORALBright Ideas Problem-Solving Skills Training

Intervention materials include instructor and user manuals, a brochure, and worksheets to be completed by the parent caregiver, initially with the help of the interventionist, during four weekly face-to-face (F2F) sessions

Sponsors

Children's Hospital Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Children Inclusion Criteria: * Male and females of any race or ethnicity, ages 0 to 21 years * Allogeneic or autologous HSCT planned with reduced intensity or myeloablative conditioning

Exclusion criteria

* Concurrent enrollment on a research study testing psychoeducational interventions for parents and/or patients Parent Inclusion Criteria: * One parent or primary caregiver per child * Able to speak, read, and write English or Spanish, and give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Bright IDEAS for parentsBaseline to 180 daysPercent eligible participants who consent/assent to participate and Number of sessions completed by enrolled participants.
Bright IDEAS AcceptabilityBetween day 60 and day 90Qualitative Interviews will assess participant satisfaction with the intervention format, timing, and content; impact; barriers; and suggestions for refinement.

Secondary

MeasureTime frameDescription
Parent AnxietyBaseline to 180 daysBeck Anxiety Inventory
Parent DepressionBaseline to 180 daysBeck Depression Inventory
Parent Problem Solving SkillsBaseline to 180 daysSocial Problem-Solving Skills Inventory-Revised Short Form
Children Symptom BurdenBaseline to 180 daysMemorial Symptoms Assessment Scale (Child Version & Parent Proxy for children ages 2-6 years)
Children Health-Related Quality of LifeBaseline to 180 daysPedsQL Cancer Module (Child Version & Parent Proxy for children ages 2-4 years)
Parent Post-traumatic StressBaseline to 180 daysImpact of events scale revised
Parent Negative AffectivityBaseline to 180 daysProfile of Mood States Short Form

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026